In addition, 12-month changes in anti-CS and anti-TOPO-F4 IgM and IgG levels variably positively correlated with changes in CRP, RA, and AS disease activity, FMD, PWV, and ccIMT over time. This evidence concerns the gene CD40LG and rheumatoid arthritis.